These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 415475)

  • 21. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3.
    Sandberg H; Bode AP; Dombrose FA; Hoechli M; Lentz BR
    Thromb Res; 1985 Jul; 39(1):63-79. PubMed ID: 3839944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostatic defects in dysproteinemias.
    Perkins HA; MacKenzie MR; Fudenberg HH
    Blood; 1970 May; 35(5):695-707. PubMed ID: 4986530
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunochemical study of 3 cases of pyroglobulinemia].
    Cattaneo R; Bazzi C; Simonati V; Balestrieri G
    Prog Immunobiol Stand; 1970; 4():199-204. PubMed ID: 4991582
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of M-components in a large municipal hospital.
    Jensen K; Hom BL; Jensen KB; Olesen H
    Dan Med Bull; 1969 Jun; 16(6):165-70. PubMed ID: 4190828
    [No Abstract]   [Full Text] [Related]  

  • 25. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
    Strachan AF; Johnson PM
    J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG myeloma and Waldenström macroglobulinemia. Coexistence and clinical manifestations in one patient.
    McNutt DR; Fudenberg HH
    Arch Intern Med; 1973 May; 131(5):731-6. PubMed ID: 4633790
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxidative stress and platelet function in multiple myeloma and renal insufficiency: clinical relations of different tests.
    Cieslar P; Másová L; Scheiner T; Rysavá J; Krízová P; Danzigová Z; Spicka I; Tesar V
    Thromb Res; 2002 Feb; 105(4):277-83. PubMed ID: 12031820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet antibody determination by platelet factor 3 assay (comparison with radiolabelled serotonin release and platelet aggregometry).
    Leone G; Breda M; Accorrà F; Bizzi B
    Ric Clin Lab; 1978; 8(3):141-7. PubMed ID: 746295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent data on monoclonal immunoglobulins].
    Seligmann M
    Nouv Rev Fr Hematol; 1970; 10(3):329-34. PubMed ID: 4195509
    [No Abstract]   [Full Text] [Related]  

  • 30. [Quantitative determination of the immunoglobulins IgG, IgA and IgM].
    Mitrică N; Sorocinschi F; Georgescu C; Steinbruh L
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(4):371-5. PubMed ID: 4210255
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
    Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
    Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet function in leprosy.
    Gupta M; Bhargava M; Kumar S; Mittal MM
    Int J Lepr Other Mycobact Dis; 1975; 43(4):327-32. PubMed ID: 1241689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasmatic immunoglobulins in the course of myelomatosis].
    Maiorca R; Scarpioni L; Cambi V; Carrara GC; Dall'Aglio P
    G Clin Med; 1965 Jul; 46(7):568-75. PubMed ID: 4159856
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple myeloma and macroglobulinemia cases in Hawaii.
    Hartman W; Farin R; Yokoyama M
    Hawaii Med J; 1967; 26(6):531-6. PubMed ID: 4169284
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunochemical studies of monoclonal gammapathies: anachronism or research prospectives?].
    Gergely J; Eckhardt S
    Orv Hetil; 1975 Jul; 116(27):1563-6. PubMed ID: 806867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Distribution of phospholipids in platelet membranes and platelet factor 3 availability in patients with chronic kidney failure].
    Krawczyk W; Dmoszyńska A; Ledwozyw A
    Pol Arch Med Wewn; 1993 Dec; 90(6):409-15. PubMed ID: 8146043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polyclonal immunoglobulins in serum in obligatory and facultative monoclonal gammopathies].
    Hrncírová L; Máchová L
    Vnitr Lek; 1982 Feb; 28(2):116-21. PubMed ID: 6801853
    [No Abstract]   [Full Text] [Related]  

  • 38. Disturbances of platelet function in patients with multiple myeloma.
    Czestochowska E; Tymiński W; Górski J; Umiastowski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):845-51. PubMed ID: 2453414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factors influencing platelet procoagulant activity in type II diabetic patients. The role of sodium-proton exchange].
    Telejko B; Kinalska I; Stelmach H; Tomasiak M
    Przegl Lek; 2003; 60(9):553-6. PubMed ID: 15065331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states.
    McGrath KM; Stuart JJ; Richards F
    Br J Haematol; 1979 Aug; 42(4):585-91. PubMed ID: 476010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.